×

Sign In

Search
Home

Novo Nordisk secures license to weight-loss drug candidate from China’s United Labs

By Thomson Reuters Mar 24, 2025 | 5:21 AM

(Reuters) -China-based United Laboratories International said on Monday it will license its weight-loss drug candidate to Danish drugmaker Novo Nordisk in a deal worth up to $2 billion.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)

US corporate profits surge in fourth quarter

US goods trade deficit narrows in February

Washington told EU to brace for more tariffs before any talks, envoys say

ECB must move policy with caution and prudence, VP says

US natgas prices ease 1% to 5-week low on lower demand, ahead of storage report

Brazil's annual inflation hits two-year high as rate hikes continue

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2025. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.